Meyka Pro banner
Aditxt, Inc.

Aditxt, Inc. (PNK: ADTX) Stock Competitors & Peer Comparison

See ADTX's competitors and their performance on the PNK and across the wider stock market.

ADTXPNK
HealthcareBiotechnology
$0.004
$0.00(2.86%)
U.S. Market opens in 21h 18m

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for ADTX and its PNK peers.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ADTX$0.00+2.86%3.7MN/A-$40.75N/A
SGMO$0.07+0.00%30.7M-0.20-$0.37N/A
ITRMF$0.05+0.00%2.7M-0.07-$0.70N/A
CASIF$0.13+0.00%2.6M-0.05-$2.68N/A
OCEA$0.00+300.00%237.3KN/A-$1.09N/A
AFMDQ$0.00+0.00%1.6KN/A-$3.61N/A
BIORQ$0.00+0.00%905N/A-$16.30N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

Sangamo Therapeutics, Inc. (PNK: SGMO)

ADTX vs SGMO Comparison July 2026

Aditxt, Inc. (PNK: ADTX) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADTX stands at 3.7M. In comparison, SGMO has a market cap of 30.7M. Regarding current trading prices, ADTX is priced at $0.00 on the PNK, while SGMO trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADTX currently has a P/E ratio of N/A, whereas SGMO's P/E ratio is -0.20. In terms of profitability, ADTX's ROE is +9.26%, compared to SGMO's ROE of +66.86%. Regarding short-term risk, ADTX is less volatile compared to SGMO. This indicates lower risk in terms of short-term price fluctuations for ADTX.Check SGMO's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions